Amplitude Healthcare Acquisition Corporation
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $100.00M |
|---|---|
| IPO Date | Nov 20, 2019 |
| CEO | Bala Venkataraman |
| Left Lead | BMO Capital Markets |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | Jasper Therapeutics |
| Deal Announced | May 6, 2021 |
| Deal Size, $M | $290.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 22, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 24, 2021 |
Formerly AMHC
JSPR
JSPRW
| Price | $20.98 $2.10 |
|---|---|
| Last closing price | $20.69 |
| H/L, today | $19.79 / $21.00 |
| H/L, 52-week | $0.39 / $3.80 |
| Volume, today | 216,680 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Amplitude Healthcare Acquisition Corporation:
- Structure and cap table
- 7 directors & officers
- 22 filings and events
- 2 underwriters
- 6 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Howard Hoffen | 55 | Chairman |
| Bala Venkataraman | 52 | Chief Executive Officer and Director |
| Kenneth Clifford | 63 | Chief Financial Officer |
| Fred Eshelman | 71 | Director |
| Ernest Mario | 81 | Director |
| Peter Dolan | 63 | Director |
| Glenn Reicin | 55 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| BMO Capital Markets | Joint BR | 5,500,000 | units |
| SVB Securities | Joint BR | 4,500,000 | |
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.